Evolution of a Simian Immunodeficiency Virus Pathogen

Author:

Edmonson Paul1,Murphey-Corb Michael2,Martin Louis N.2,Delahunty Claire3,Heeney Jonathan4,Kornfeld Hardy5,Donahue Peter R.6,Learn Gerald H.7,Hood Leroy3,Mullins James I.78

Affiliation:

1. Departments of Pathology,1

2. Tulane Regional Primate Research Center, Covington, Louisiana 704332;

3. Molecular Biotechnology,3

4. Virology, Laboratory of Viral Pathogenesis, Biomedical Primate Research Centre, Rijswijk, The Netherlands4;

5. Boston University School of Medicine, Boston, Massachusetts 021185; and

6. Children’s Hospital, St. Paul, Minnesota 551026

7. Microbiology,7 and

8. Medicine,8 University of Washington, Seattle, Washington 98195;

Abstract

ABSTRACT Analysis of disease induction by simian immunodeficiency viruses (SIV) in macaques was initially hampered by a lack of molecularly defined pathogenic strains. The first molecularly cloned SIV strains inoculated into macaques, SIVmacBK28 and SIVmacBK44 (hereafter designated BK28 and BK44, respectively), were cases in point, since they failed to induce disease within 1 year postinoculation in any inoculated animal. Here we report the natural history of infection with BK28 and BK44 in inoculated rhesus macaques and efforts to increase the pathogenicity of BK28 through genetic manipulation and in vivo passage. BK44 infection resulted in no disease in four animals infected for more than 7 years, whereas BK28 induced disease in less than half of animals monitored for up to 7 years. Elongation of the BK28 transmembrane protein (TM) coding sequence truncated by prior passage in human cells marginally increased pathogenicity, with two of four animals dying in the third year and one dying in the seventh year of infection. Modification of the BK28 long terminal repeat to include four consensus nuclear factor SP1 and two consensus NF-κB binding sites enhanced early virus replication without augmenting pathogenicity. In contrast, in vivo passage of BK28 from the first animal to die from immunodeficiency disease (1.5 years after infection) resulted in a consistently pathogenic strain and a 50% survival time of about 1.3 years, thus corresponding to one of the most pathogenic SIV strains identified to date. To determine whether the diverse viral quasispecies that evolved during in vivo passage was required for pathogenicity or whether a more virulent virus variant had evolved, we generated a molecular clone composed of the 3′ half of the viral genome derived from the in vivo-passaged virus (H824) fused with the 5′ half of the BK28 genome. Kinetics of disease induction with this cloned virus (BK28/H824) were similar to those with the in vivo-passaged virus, with four of five animals surviving less than 1.7 years. Thus, evolution of variants with enhanced pathogenicity can account for the increased pathogenicity of this SIV strain. The genetic changes responsible for this virulent transformation included at most 59 point mutations and 3 length-change mutations. The critical mutations were likely to have been multiple and dispersed, including elongation of the TM and Nef coding sequences; changes in RNA splice donor and acceptor sites, TATA box sites, and Sp1 sites; multiple changes in the V2 region of SU, including a consensus neutralization epitope; and five new N-linked glycosylation sites in SU.

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Reference58 articles.

1. Barry P. Pratt-Lowe E. Luciw P. A. Electroporation of T-cell and macrophage cell lines. Methods in electroporation. 1988 Bio-Rad Laboratories Richmond Calif

2. N-glycosylation of HIV-gp120 may constrain recognition by T lymphocytes;Botarelli P.;J. Immunol.,1991

3. Burns D. P. W. Ph.D. thesis. 1992 Harvard University Cambridge Mass

4. Selection of genetic variants of simian immunodeficiency virus in persistently infected rhesus monkeys

5. The cytoplasmic domain of simian immunodeficiency virus transmembrane protein modulates infectivity

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3